Syschem (India) Ltd.
| BSE: 531173 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE121D01036 |
| BSE 00:00 | 26 Feb | 8.33 |
0 (0.00%) |
OPEN
8.15 |
HIGH
8.60 |
LOW
7.99 |
| NSE 05:30 | 01 Jan | Syschem (India) Ltd |
| OPEN | 8.15 |
| PREVIOUS CLOSE | 8.33 |
| VOLUME | 5581 |
| 52-Week high | 9.45 |
| 52-Week low | 5.44 |
| P/E | |
| Mkt Cap.(Rs cr) | 18 |
| Buy Price | 7.80 |
| Buy Qty | 50.00 |
| Sell Price | 8.40 |
| Sell Qty | 500.00 |
Syschem (India) Ltd. (SYSCHEMINDIA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 602.70 | 7.40 | 1.24 | 3211.14 |
| Dr Reddy's Labs | 4457.80 | 33.20 | 0.75 | 2937.70 |
| Cipla | 792.45 | 5.90 | 0.75 | 2318.17 |
| Aurobindo Pharma | 853.80 | -1.10 | -0.13 | 1872.74 |
| Cadila Health. | 435.30 | 0.55 | 0.13 | 1412.90 |
| Divi's Lab. | 3432.10 | 63.85 | 1.90 | 1372.71 |
| Glenmark Pharma. | 466.00 | -1.00 | -0.21 | 1354.55 |
| Alkem Lab | 2748.40 | 29.80 | 1.10 | 1264.42 |
| Alembic Pharma | 926.70 | 7.55 | 0.82 | 969.40 |
| Torrent Pharma. | 2414.15 | -15.40 | -0.63 | 938.51 |
| Gland Pharma | 2421.05 | 19.55 | 0.81 | 772.86 |
| Lupin | 1021.35 | 2.85 | 0.28 | 727.55 |
| Ipca Labs. | 1833.20 | -16.10 | -0.87 | 652.46 |
| Abbott India | 14309.00 | -87.65 | -0.61 | 592.93 |
| Fortis Health. | 163.40 | 4.95 | 3.12 | 513.33 |
| Pfizer | 4547.95 | -2.75 | -0.06 | 509.13 |
| Natco Pharma | 816.95 | 4.35 | 0.54 | 474.50 |
| Apollo Hospitals | 3035.10 | -25.40 | -0.83 | 470.30 |
| Granules India | 328.35 | 4.95 | 1.53 | 444.07 |
| Ajanta Pharma | 1750.00 | 2.50 | 0.14 | 441.13 |
Quick Links for Syschem (India):
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
